COTA Healthcare
Database of clinical cancer studies
- 201-500 employees
- Healthcare
- B2B
- Data storage
- Biology
- SaaS
- Data Analysis
- Science
- Financial District, New York, NY
Jump to section
Company mission
Cota's mission is to provide a comprehensive picture of cancer that can be used to advance care and research.
33% employee growth in 12 months
Our take
Founded by a group of doctors, engineers, and data scientists, COTA Healthcare builds solutions for healthcare to analyse, visualise, report, and manage real-world evidence and deliver precision medicine. COTA partners with providers, payers, and life science companies to improve patient outcomes, make clinical sense of claims data, and accelerate drug development.
COTA is now well established, although by no means the only player in the global AI healthcare market, which is expected to reach $39.5 billion by 2026. Competition from larger oncology-focused companies such as Flatiron Health and Tempus led to COTA's merger with Verana Health, a patient care data company, in 2026.
Now with access to over 95 million patients and 17 of the top 20 biopharma companies, the merged entity gained $52 million in extra equity investment. COTA will continue its growth efforts, expanding its oncology real-world data, analytics, and services for its audiences in the years to come.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- 401k / retirement
- Annual bonus
- Medical / dental / vision benefits
- Monthly commuter benefits
- Stock option grants
- Unlimited paid time off
- Paid sick time – 40 hrs/year
- 11 paid holidays per year
- Paid Parental leave – 8 weeks
- Company team building events
- Educational lunch & learns
- Cause-driven employees
- Employee-led Diversity & Inclusion committee
- Healthy snacks
- Gourmet coffee and cold brew
Funding (last 2 of 4 rounds)
Nov 2020
$10m
CONVERTIBLE
Feb 2018
$40m
SERIES C
Total funding: $75m
Leadership
Sujay Jadhav
(President & CEO)Is also the CEO of Verana Health. Previously worked as the Global Vice President of Oracle, was a Board Member at Bio-Optronics and was the SVP of Global Corporate Strategy & Development at Model N.